View as Webpage


Date: Aug. 4, 2022


The Digest - GW Clinical Enterprise

**This email contains important COVID-19 information and updates. Please ensure that you read these emails in their entirety. Thank you!**

GW MFA | GW Hospital | GW SMHS

The GW Medical Faculty Associates

UPDATE: The GW MFA COVID-19 vaccine clinic will close Friday, Aug. 5, at 3 p.m., and will no longer offer COVID-19 vaccines, following the conclusion of its DC Department of Health grant. To find a vaccine center in your area, please visit Vaccines.gov.

We Are Still in a COVID Wave

The Omicron subvariants BA.5 and BA.4 are still causing a large wave of infections throughout the United States. They are the most infectious COVID variants to date.

  • Please continue to mask in all shared spaces of the GW MFA, including nonclinical spaces. 
  • Please avoid eating indoors in groups given the high risk of transmission posed by this subvariant.

 

Following are recommended therapies for early treatment of COVID-19 among high-risk individuals:

Nirmatrelvir/ritonavir (PAXLOVID) and the monoclonal antibody (BEBLETOVIMAB) continue to have efficacy for all currently circulating Omicron subvariants. Early treatment can substantially reduce the risk of progression to severe disease.

 

Paxlovid (within five days of symptom onset): Authorized for treating high-risk outpatients with mild to moderate COVID. It is active against all variants and subvariants to date and reduced the risk of severe COVID by 89%. Please refer to this guidance for criteria and details. Please look up potential drug-drug interactions here. Paxlovid is available at the MFA Pharmacy and other pharmacies. Please indicate the patient’s renal function when prescribing Paxlovid. This drug can now be prescribed by pharmacists as well as other licensed practitioners.

 

Bebletovimab (within seven days of symptom onset): This therapeutic monoclonal antibody is available at GWUH in limited quantity. It is authorized for high-risk patients with mild to moderate COVID who meet the criteria outlined in these guidelines.

GW Hospital


No Updates

The GW SMHS

REMINDER: GW COVID-19 Public Health Protocols 


Indoor Mask Requirement

With the 2022-23 academic year underway, it’s important to remember that the university’s indoor mask requirement remains in place. This policy is evaluated regularly, and we will update you with any changes. 


Testing Protocols

Asymptomatic COVID-19 testing is available on-demand for all GW students, faculty, and staff who need or want a routine COVID test.

For more information click here to visit the University’s Onward GW website.

This email is intended to serve as a digest of all messaging for our clinical faculty, students, and staff. This email is distributed at the close of business weekly, as we are managing operations during the COVID-19 pandemic. 


If you have feedback, please feel free to send to SMHSNews@gwu.edu.

GW-MFA-interim-logo.png
gw_sch_smhs_full_2cs_pos.jpg